CHRONIC KIDNEY DISEASE AND HYPERTENSION
Clinical trials for CHRONIC KIDNEY DISEASE AND HYPERTENSION explained in plain language.
Never miss a new study
Get alerted when new CHRONIC KIDNEY DISEASE AND HYPERTENSION trials appear
Sign up with your email to follow new studies for CHRONIC KIDNEY DISEASE AND HYPERTENSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to slow kidney failure and save hearts in 5,000-Patient trial
Disease control Recruiting nowThis phase 3 study tests whether adding baxdrostat to standard dapagliflozin treatment can better prevent kidney failure, heart failure, or heart-related death in 5,000 adults with chronic kidney disease and high blood pressure. Participants will receive either the combination or…
Matched conditions: CHRONIC KIDNEY DISEASE AND HYPERTENSION
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 26, 2026 08:09 UTC
-
Could a Two-Drug punch shield kidneys from high blood pressure damage?
Disease control Recruiting nowThis study tests whether adding dapagliflozin to baxdrostat better reduces protein in urine (a sign of kidney damage) than baxdrostat alone in 218 adults with chronic kidney disease and high blood pressure. Participants must already be on stable blood pressure medication. The goa…
Matched conditions: CHRONIC KIDNEY DISEASE AND HYPERTENSION
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 26, 2026 07:25 UTC